Euglena Overview

  • Founded
  • 2005
Founded
  • Status
  • Public
  • Employees
  • 419
Employees
  • Stock Symbol
  • 2931
Stock Symbol
  • Investments
  • 6
  • Share Price
  • $7.66
  • (As of Friday Closing)

Euglena General Information

Description

euglena Co Ltd is a biotechnology company that researches, develops, produces, and markets microalgae. The company focuses on commercializing its algae research for a variety of uses, including functional foods and cosmetics. Euglena also researches ways to use its microalgae for carbon capture and biofuel production.

Contact Information

Website
www.euglena.jp
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Food Products
Other Industries
Personal Products
Stock Exchange
TKS
Primary Office
  • Tamachi
  • Minato-ku
  • Tokyo
  • Japan
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Euglena Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.66 $7.49 $7.24 - $11.86 $840M 110M 1.33M -$0.10

Euglena Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 30-Sep-2020 FY 2019 30-Sep-2019 FY 2018 30-Sep-2018
EV 912,355 744,549 734,140 654,262
Revenue 149,230 123,480 126,928 137,354
EBITDA (6,569) (78,510) (3,117)
Net Income (9,056) (13,785) (89,042) (11,334)
Total Assets 533,923 145,273 159,318 192,075
Total Debt 234,909 35,623 33,923 33,880
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Euglena Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Euglena‘s full profile, request access.

Request a free trial

Euglena Patents

Euglena Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190054127-A1 Antiviral agent and antiviral food Abandoned 04-Mar-2016 000000000
JP-2017160189-A Antiviral agent and antiviral food Granted 04-Mar-2016 000000000
JP-6139813-B1 Antiviral agent and antiviral food Active 04-Mar-2016 000000000
US-20180112175-A1 Method for producing an organic acid using euglena Abandoned 08-May-2015 00000000
JP-6745513-B2 Method for producing organic acid using euglena Active 08-May-2015 C12P7/40

Euglena Executive Team (4)

Name Title Board Seat Contact Info
Izumo Mitsuru Founder & Chief Executive Officer
Akihiko Nagata Chief Financial Officer & Chief Operating Officer
Etsuko Okajima Chief Human Resources Officer
Suzuki Kengo Co-Owner
To view Euglena’s complete executive team members history, request access »

Euglena Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Euglena Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Euglena‘s full profile, request access.

Request a free trial

Euglena Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0'000 01-Feb-2021 0000000000 00000 Food Products
0000000 02-Mar-2020 00000 00000 00 Clinics/Outpatient Services
00000000000000 25-May-2018 0000 00000 00.000 Biotechnology
0000000 15-May-2018 00000 00000 00 Clinics/Outpatient Services
Art (Japan) 01-May-2015 Merger/Acquisition 00.000 Food Products
You’re viewing 5 of 6 investments and acquisitions. Get the full list »